Phio Pharmaceuticals Corp.
Immunotherapy of cancer

Abstract:

Immunogenic modulators and compositions comprising oligonucleotide agents capable of inhibiting suppression of immune response by reducing expression of one or more gene involved with an immune suppression mechanism.